| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 46 |
| 1 | ASPIRIN | 34 |
| 2 | ASPIRIN 325 MG | 34 |
| 3 | ASPIRIN 81 MG | 34 |
| 4 | RISANKIZUMAB-RZAA | 31 |
| 5 | UPADACITINIB | 31 |
| 6 | METHOTREXATE SODIUM | 27 |
| 7 | DICLOFENAC SODIUM | 26 |
| 8 | DICLOFENAC | 25 |
| 9 | AMBRISENTAN | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BUTALBITAL, ASPIRIN, AND CAFFEINE | 4 | 0.0233 |
| 1 | CASPOFUNGIN ACETATE | 3 | 0.0019 |
| 2 | CERLIPONASE ALFA | 1 | 0.0019 |
| 3 | ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 1 | 0.0017 |
| 4 | INFLIXIMAB-DYYB | 5 | 0.0015 |
| 5 | MEBENDAZOLE | 1 | 0.0013 |
| 6 | ZICONOTIDE ACETATE | 3 | 0.0012 |
| 7 | BACLOFEN INJECTION | 3 | 0.0010 |
| 8 | ALPROSTADIL | 3 | 0.0008 |
| 9 | CEFUROXIME SODIUM | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 64 |
| 1 | Corticosteroid [EPC] | 43 |
| 2 | Janus Kinase Inhibitor [EPC] | 34 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 34 |
| 4 | Interleukin-23 Antagonist [EPC] | 33 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 31 |
| 6 | Vitamin C [EPC] | 30 |
| 7 | Phosphodiesterase 5 Inhibitor [EPC] | 29 |
| 8 | Endothelin Receptor Antagonist [EPC] | 26 |
| 9 | Kinase Inhibitor [EPC] | 26 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Provitamin D2 Compound [EPC] | 24 | 0.0008 |
| 2 | Osmotic Diuretic [EPC] | 3 | 0.0006 |
| 3 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0005 |
| 4 | Barbiturate [EPC] | 4 | 0.0003 |
| 5 | Anthelmintic [EPC] | 1 | 0.0003 |
| 6 | Interleukin-23 Antagonist [EPC] | 33 | 0.0003 |
| 7 | Interleukin-17A Antagonist [EPC] | 9 | 0.0002 |
| 8 | Antiseptic [EPC] | 1 | 0.0002 |
| 9 | Antiparasitic [EPC] | 1 | 0.0002 |